Security principle
Clinical intelligence should increase with data, but patient trust should not decrease with scale.
Data categories
Consensus classifies data by sensitivity and purpose. The engine’s runtime facts include profile fields, biomarker states, derived flags, specimen quality, and longitudinal data, so privacy controls must cover more than raw lab values.Purpose limitation
Every data category should have a defined purpose. This principle should become a system rule, not only a policy statement.
Ancestry is used only as a clinical input for documented biological corrections, with consent and transparency, and never for any purpose other than clinical calibration.
Consent model
Consent should be granular enough to match the sensitivity of the data. The patient should not be forced to give broad permission for every possible use. A patient may agree to clinical interpretation but not to de-identified learning, or share labs but not genotype. The system respects these distinctions. A basic consent model includes care operations, lab interpretation, sensitive context (pregnancy, medications, contraindications), genetic data, ancestry-related context, de-identified learning, communications, and partner sharing.Sensitive calibration inputs
Ancestry, genotype, and phenotype inputs require special handling. They can improve interpretation, but they also create ethical and legal risk if misused, so the system treats them as restricted clinical inputs:- Express consent — the patient must understand why the input is requested.
- Purpose restriction — use only for calibration and clinical review.
- No visual inference — never infer ancestry or genotype from appearance.
- Specific mechanism — apply only to documented genotype, phenotype, or biological mechanism.
- Conservative uncertainty — route missing or conflicting signals to review.
- Clinician visibility — show how the input affected interpretation.
- Audit trace — record when and why the input was used.
- Access restriction — limit access to authorized roles.
- De-identification — use for learning only with separate consent and governance.
Access control
Access follows least privilege. A safe system assumes that not everyone who works on the product should be able to see clinical data.Segregation of clinical data
Clinical data should be segregated across multiple boundaries, because data leakage between patients, organizations, or purposes can cause harm even if the clinical engine works correctly: patient-level, organization-level, role-level, environment, clinical versus payment, raw versus de-identified, genetic data, and agent log segregation.Audit logging
Every sensitive action should leave a trace. Audit logging connects clinical traceability and security traceability — decision records already function as the audit unit for clinical interpretation, carrying inputs, rules fired, calibrations applied, resulting state, and cited evidence. Audit logs should record patient data viewed, lab result uploaded, lab value normalized, decision generated, clinician review completed, patient message released, consent updated, sensitive input accessed, rule changed, calibration applied, data exported, agent output generated, and security exceptions.Decision trace as privacy-sensitive data
Decision traces are useful, but they are also sensitive. A decision trace may reveal patient identity, lab values, medication context, pregnancy status, genotype or phenotype, ancestry context, the rule fired, the calibration applied, a treatment flag, the clinician decision, and the evidence source.De-identified learning loop
The engine improves as decision records, calibrations, and outcomes accumulate, but improvement must be governed. Accumulated decision records, inputs, calibrations, and outcomes form the longitudinal dataset that can refine calibrations over time, and de-identified data may improve calibrations only with separate consent.1
Confirm consent
Confirm patient consent for de-identified learning.
2
Remove direct identifiers
Strip direct identifiers from the dataset.
3
Minimize quasi-identifiers
Reduce quasi-identifiers where possible.
4
Separate datasets
Separate the learning dataset from the care-delivery record.
5
Preserve linkage
Preserve calibration, rule, and outcome linkage in de-identified form.
6
Restrict access
Restrict access to approved reviewers.
7
Monitor re-identification risk
Continuously monitor re-identification risk.
8
Govern findings
Use findings only through Medical Director governance.
9
Update through lifecycle
Update rules through lifecycle, not direct model drift.
10
Record provenance
Record which learning dataset supported any change.
De-identification is not magic
De-identification reduces risk, but it does not eliminate it — especially for clinical, genomic, ancestry-linked, and longitudinal data. Rare combinations of lab patterns, genotype, age, geography, and clinical history can increase re-identification risk. The system treats de-identified data as protected improvement data, not as public or unrestricted data.AI-agent data handling
AI agents may touch sensitive information during intake, summarization, follow-up, and clinician preparation. Their access should be narrow and tool-based: minimum necessary, tool-grounded, role-aware, no hidden clinical logic, no uncontrolled PHI exposure, output logging, source visibility, and escalation of ambiguous outputs. Privacy and safety are connected. An agent that sees too much, remembers too much, or generates beyond source data creates both data risk and clinical risk.Model-provider governance
Model-provider governance should be finalized before external deployment at scale. The governance checklist should answer: provider identity, model version, processing region, data retention, training use, encryption, access logs, PHI minimization, contractual terms (healthcare data protections), change management, failure mode, and incident response.Encryption and secrets management
Secrets management and encryption in transit and at rest are required areas, with specific standards still to be confirmed. These controls should be implemented and documented before broader clinical deployment. The final standard should cover encryption in transit (app, API, lab integrations, model calls, clinician portals), encryption at rest (databases, backups, logs, files, decision traces), key management, secrets storage (no secrets in code, documents, prompts, or shared files), credential rotation, environment secrets, vendor credentials, and emergency break-glass access with audit logging.Data retention
Retention should be intentional. Different data types may require different retention periods depending on clinical, legal, operational, and consent requirements. The main rule: do not keep sensitive data indefinitely without a defined clinical, legal, or governance reason.Patient rights and data transparency
The patient should be able to understand how their data is used. Privacy should not be hidden in legal language only; it should be visible in the patient experience.Partner and vendor data sharing
Consensus may need to share data with clinics, labs, payment providers, communication tools, AI providers, cloud vendors, and other operational partners. Vendor decisions are security decisions. Each partner relationship should define the data shared, purpose, legal basis or consent, security controls, subprocessors, region, retention, deletion, audit rights, incident notification, and the clinical boundary (the partner does not make unauthorized clinical decisions).Security incident response
A clinical system needs a defined incident response plan. The plan should connect technical containment with clinical review — a data incident can become a medical safety incident if it affects interpretation, follow-up, or patient communication.Backup and recovery
Backups should protect not only data, but clinical reproducibility. A restored system must not lose the ability to explain prior decisions. The system should be able to recover patient records, lab values, decision traces, rule versions, calibration versions, the evidence library, consent records, audit logs, clinician decisions, patient messages, and schema versions.Security governance metrics
Security and privacy should be measurable. These metrics should become part of the company’s operating dashboard.Summary
Security, privacy, and data governance are part of the clinical architecture of Consensus Center. The engine depends on sensitive data, so access must be limited. The system uses decision traces, so audit records must be protected. Calibration may use ancestry or genotype, so consent and purpose limitation must be strict. Learning loops may improve the engine, but only with de-identification and separate consent. AI agents may coordinate care, but their data access must be narrow and logged. Vendors may support infrastructure, but their data handling must be confirmed. Security incidents must connect technical response with clinical review.The goal is not only compliance. The goal is trust. A preventive health system should help patients understand their biology without making them lose control of their data.